SLC5A2 and type 2 diabetes mellitus: On the other hand, phloridzin, one of the most frequently found DHCs, served as the lead structure for the development of sodium/glucose cotransporter 2 (SGLT2) inhibitors like dapagliflozin, approved drugs for the treatment of type 2 diabetes [22].